Skip to main content

Table 2 Clinical outcomes and postoperative complications after HAAM implantation surgery

From: Human acellular amniotic membrane implantation for lower third nasal reconstruction: a promising therapy to promote wound healing

Variable

HAAM group

Control group

P value

Haemostasis time (min, mean ± SD)

3.11 ± 1.14

5.48 ± 1.53

< 0.001

Disappearance time of pain (hour, mean ± SD)

6.36 ± 1.90

11.11 ± 3.55

< 0.001

Time of scab formation (day, mean ± SD)

4.75 ± 1.13

6.84 ± 1.07

< 0.001

Time of scab detachment (day, mean ± SD)

6.70 ± 0.98

8.72 ± 1.99

< 0.001

Healing rate (mm, mean ± SD)

 0–5 mm

3.54 ± 0.88

3.29 ± 0.69

0.30

 5–10 mm

6.79 ± 1.25

5.26 ± 0.97

< 0.001

 > 10 mm

10.27 ± 1.62

8.45 ± 0.93

< 0.05

Bleeding (n)

2

7

< 0.001

Wound infection (n)

4

14

< 0.05

Scar (n)

4

12

< 0.05

  1. HAAM human acellular amniotic membrane, SD standard deviation